Loading…
Homocysteine, Vitamin B 12 and Folic Acid Levels in Psoriatic Patients and Correlation with Disease Severity
Hyperhomocysteinaemia represents an independent risk factor for atherosclerotic cardiovascular disease, stroke, peripheral arterial occlusive disease and venous thrombosis. Psoriasis is a chronic inflammatory skin disease associated with increased atherothrombosis and cardiovascular risk profile. Th...
Saved in:
Published in: | International journal of immunopathology and pharmacology 2010-07, Vol.23 (3), p.911-916 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c177t-1b0682ff81bdced0bf47bd605bceb097416325bda42c911a3fb6a134d9bad7a33 |
---|---|
cites | cdi_FETCH-LOGICAL-c177t-1b0682ff81bdced0bf47bd605bceb097416325bda42c911a3fb6a134d9bad7a33 |
container_end_page | 916 |
container_issue | 3 |
container_start_page | 911 |
container_title | International journal of immunopathology and pharmacology |
container_volume | 23 |
creator | Brazzelli, V. Grasso, V. Fornara, L. Moggio, E. Gamba, G. Villani, S. Borroni, G. |
description | Hyperhomocysteinaemia represents an independent risk factor for atherosclerotic cardiovascular disease, stroke, peripheral arterial occlusive disease and venous thrombosis. Psoriasis is a chronic inflammatory skin disease associated with increased atherothrombosis and cardiovascular risk profile. The aim of this study is to investigate homocysteine, folic acid and vitamin B12 levels in a cohort of psoriatic patients and its relationship with the severity of the disease. A retrospective observational study in 98 patients with chronic plaque psoriasis and 98 healthy controls was performed. Total plasma homocysteine level, folic acid, vitamin B 12 and PASI index were assessed in every patient. Patients with psoriasis had plasma homocysteine levels higher than controls (57% of cases and 25% of controls; p |
doi_str_mv | 10.1177/039463201002300327 |
format | article |
fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1177_039463201002300327</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1177_039463201002300327</sourcerecordid><originalsourceid>FETCH-LOGICAL-c177t-1b0682ff81bdced0bf47bd605bceb097416325bda42c911a3fb6a134d9bad7a33</originalsourceid><addsrcrecordid>eNplkN1KAzEQhYMoWLQv4FUewNWZJLvZvazVWqFgwZ_bJX-Lke1GkqD07U3VO2_mwJxvBs4h5ALhClHKa-CdaDgDBGAcgDN5RGYM6raSvBXHZHYAqgNxSuYpvQMUlIu6xRkZ12EXzD5l5yd3SV99Vjs_0RuKjKrJ0lUYvaEL4y3duE83JlrcbQrRq1yMbZluyumHXYYY3Vg2YaJfPr_RW5-cSo4-lcvo8_6cnAxqTG7-p2fkZXX3vFxXm8f7h-ViU5kSJ1eooWnZMLSorXEW9CCktg3U2jgNnRRYstTaKsFMh6j4oBuFXNhOKysV52eE_f41MaQU3dB_RL9Tcd8j9IfK-v-V8W8UDF65</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Homocysteine, Vitamin B 12 and Folic Acid Levels in Psoriatic Patients and Correlation with Disease Severity</title><source>SAGE Open Access</source><creator>Brazzelli, V. ; Grasso, V. ; Fornara, L. ; Moggio, E. ; Gamba, G. ; Villani, S. ; Borroni, G.</creator><creatorcontrib>Brazzelli, V. ; Grasso, V. ; Fornara, L. ; Moggio, E. ; Gamba, G. ; Villani, S. ; Borroni, G.</creatorcontrib><description>Hyperhomocysteinaemia represents an independent risk factor for atherosclerotic cardiovascular disease, stroke, peripheral arterial occlusive disease and venous thrombosis. Psoriasis is a chronic inflammatory skin disease associated with increased atherothrombosis and cardiovascular risk profile. The aim of this study is to investigate homocysteine, folic acid and vitamin B12 levels in a cohort of psoriatic patients and its relationship with the severity of the disease. A retrospective observational study in 98 patients with chronic plaque psoriasis and 98 healthy controls was performed. Total plasma homocysteine level, folic acid, vitamin B 12 and PASI index were assessed in every patient. Patients with psoriasis had plasma homocysteine levels higher than controls (57% of cases and 25% of controls; p<0.0001). Folic acid and vitamin B 12 plasma levels were lower in psoriatic patients than in controls (p = NS), lower levels of vitamin B 12 were found in patients with hyperhomocysteinaemia compared to patients with a normal value of homocysteine (p = 0.0009). The severity of psoriasis assessed according to PASI (19.51±16.26) did not directly correlate either with higher levels of homocysteine or with vitamin B 12 and folic acid plasma levels. In conclusion, a significantly higher prevalence of hyperhomocysteinaemia was found in psoriatic patients compared to healthy controls. A significant correlation between hyperhomocysteinaemia and lower vitamin B 12 levels, but not folic acid, was evidenced. On the contrary, our data do not correlate the high level of homocysteine with higher PASI scores or psoriasis type, suggesting that homocysteine level can be considered an independent risk factor in psoriatic patients.</description><identifier>ISSN: 0394-6320</identifier><identifier>EISSN: 2058-7384</identifier><identifier>DOI: 10.1177/039463201002300327</identifier><language>eng</language><ispartof>International journal of immunopathology and pharmacology, 2010-07, Vol.23 (3), p.911-916</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c177t-1b0682ff81bdced0bf47bd605bceb097416325bda42c911a3fb6a134d9bad7a33</citedby><cites>FETCH-LOGICAL-c177t-1b0682ff81bdced0bf47bd605bceb097416325bda42c911a3fb6a134d9bad7a33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Brazzelli, V.</creatorcontrib><creatorcontrib>Grasso, V.</creatorcontrib><creatorcontrib>Fornara, L.</creatorcontrib><creatorcontrib>Moggio, E.</creatorcontrib><creatorcontrib>Gamba, G.</creatorcontrib><creatorcontrib>Villani, S.</creatorcontrib><creatorcontrib>Borroni, G.</creatorcontrib><title>Homocysteine, Vitamin B 12 and Folic Acid Levels in Psoriatic Patients and Correlation with Disease Severity</title><title>International journal of immunopathology and pharmacology</title><description>Hyperhomocysteinaemia represents an independent risk factor for atherosclerotic cardiovascular disease, stroke, peripheral arterial occlusive disease and venous thrombosis. Psoriasis is a chronic inflammatory skin disease associated with increased atherothrombosis and cardiovascular risk profile. The aim of this study is to investigate homocysteine, folic acid and vitamin B12 levels in a cohort of psoriatic patients and its relationship with the severity of the disease. A retrospective observational study in 98 patients with chronic plaque psoriasis and 98 healthy controls was performed. Total plasma homocysteine level, folic acid, vitamin B 12 and PASI index were assessed in every patient. Patients with psoriasis had plasma homocysteine levels higher than controls (57% of cases and 25% of controls; p<0.0001). Folic acid and vitamin B 12 plasma levels were lower in psoriatic patients than in controls (p = NS), lower levels of vitamin B 12 were found in patients with hyperhomocysteinaemia compared to patients with a normal value of homocysteine (p = 0.0009). The severity of psoriasis assessed according to PASI (19.51±16.26) did not directly correlate either with higher levels of homocysteine or with vitamin B 12 and folic acid plasma levels. In conclusion, a significantly higher prevalence of hyperhomocysteinaemia was found in psoriatic patients compared to healthy controls. A significant correlation between hyperhomocysteinaemia and lower vitamin B 12 levels, but not folic acid, was evidenced. On the contrary, our data do not correlate the high level of homocysteine with higher PASI scores or psoriasis type, suggesting that homocysteine level can be considered an independent risk factor in psoriatic patients.</description><issn>0394-6320</issn><issn>2058-7384</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNplkN1KAzEQhYMoWLQv4FUewNWZJLvZvazVWqFgwZ_bJX-Lke1GkqD07U3VO2_mwJxvBs4h5ALhClHKa-CdaDgDBGAcgDN5RGYM6raSvBXHZHYAqgNxSuYpvQMUlIu6xRkZ12EXzD5l5yd3SV99Vjs_0RuKjKrJ0lUYvaEL4y3duE83JlrcbQrRq1yMbZluyumHXYYY3Vg2YaJfPr_RW5-cSo4-lcvo8_6cnAxqTG7-p2fkZXX3vFxXm8f7h-ViU5kSJ1eooWnZMLSorXEW9CCktg3U2jgNnRRYstTaKsFMh6j4oBuFXNhOKysV52eE_f41MaQU3dB_RL9Tcd8j9IfK-v-V8W8UDF65</recordid><startdate>201007</startdate><enddate>201007</enddate><creator>Brazzelli, V.</creator><creator>Grasso, V.</creator><creator>Fornara, L.</creator><creator>Moggio, E.</creator><creator>Gamba, G.</creator><creator>Villani, S.</creator><creator>Borroni, G.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201007</creationdate><title>Homocysteine, Vitamin B 12 and Folic Acid Levels in Psoriatic Patients and Correlation with Disease Severity</title><author>Brazzelli, V. ; Grasso, V. ; Fornara, L. ; Moggio, E. ; Gamba, G. ; Villani, S. ; Borroni, G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c177t-1b0682ff81bdced0bf47bd605bceb097416325bda42c911a3fb6a134d9bad7a33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brazzelli, V.</creatorcontrib><creatorcontrib>Grasso, V.</creatorcontrib><creatorcontrib>Fornara, L.</creatorcontrib><creatorcontrib>Moggio, E.</creatorcontrib><creatorcontrib>Gamba, G.</creatorcontrib><creatorcontrib>Villani, S.</creatorcontrib><creatorcontrib>Borroni, G.</creatorcontrib><collection>CrossRef</collection><jtitle>International journal of immunopathology and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brazzelli, V.</au><au>Grasso, V.</au><au>Fornara, L.</au><au>Moggio, E.</au><au>Gamba, G.</au><au>Villani, S.</au><au>Borroni, G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Homocysteine, Vitamin B 12 and Folic Acid Levels in Psoriatic Patients and Correlation with Disease Severity</atitle><jtitle>International journal of immunopathology and pharmacology</jtitle><date>2010-07</date><risdate>2010</risdate><volume>23</volume><issue>3</issue><spage>911</spage><epage>916</epage><pages>911-916</pages><issn>0394-6320</issn><eissn>2058-7384</eissn><abstract>Hyperhomocysteinaemia represents an independent risk factor for atherosclerotic cardiovascular disease, stroke, peripheral arterial occlusive disease and venous thrombosis. Psoriasis is a chronic inflammatory skin disease associated with increased atherothrombosis and cardiovascular risk profile. The aim of this study is to investigate homocysteine, folic acid and vitamin B12 levels in a cohort of psoriatic patients and its relationship with the severity of the disease. A retrospective observational study in 98 patients with chronic plaque psoriasis and 98 healthy controls was performed. Total plasma homocysteine level, folic acid, vitamin B 12 and PASI index were assessed in every patient. Patients with psoriasis had plasma homocysteine levels higher than controls (57% of cases and 25% of controls; p<0.0001). Folic acid and vitamin B 12 plasma levels were lower in psoriatic patients than in controls (p = NS), lower levels of vitamin B 12 were found in patients with hyperhomocysteinaemia compared to patients with a normal value of homocysteine (p = 0.0009). The severity of psoriasis assessed according to PASI (19.51±16.26) did not directly correlate either with higher levels of homocysteine or with vitamin B 12 and folic acid plasma levels. In conclusion, a significantly higher prevalence of hyperhomocysteinaemia was found in psoriatic patients compared to healthy controls. A significant correlation between hyperhomocysteinaemia and lower vitamin B 12 levels, but not folic acid, was evidenced. On the contrary, our data do not correlate the high level of homocysteine with higher PASI scores or psoriasis type, suggesting that homocysteine level can be considered an independent risk factor in psoriatic patients.</abstract><doi>10.1177/039463201002300327</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0394-6320 |
ispartof | International journal of immunopathology and pharmacology, 2010-07, Vol.23 (3), p.911-916 |
issn | 0394-6320 2058-7384 |
language | eng |
recordid | cdi_crossref_primary_10_1177_039463201002300327 |
source | SAGE Open Access |
title | Homocysteine, Vitamin B 12 and Folic Acid Levels in Psoriatic Patients and Correlation with Disease Severity |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T16%3A47%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Homocysteine,%20Vitamin%20B%2012%20and%20Folic%20Acid%20Levels%20in%20Psoriatic%20Patients%20and%20Correlation%20with%20Disease%20Severity&rft.jtitle=International%20journal%20of%20immunopathology%20and%20pharmacology&rft.au=Brazzelli,%20V.&rft.date=2010-07&rft.volume=23&rft.issue=3&rft.spage=911&rft.epage=916&rft.pages=911-916&rft.issn=0394-6320&rft.eissn=2058-7384&rft_id=info:doi/10.1177/039463201002300327&rft_dat=%3Ccrossref%3E10_1177_039463201002300327%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c177t-1b0682ff81bdced0bf47bd605bceb097416325bda42c911a3fb6a134d9bad7a33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |